Crossmark

Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study

Crossref DOI link: https://doi.org/10.1016/j.reuma.2022.08.001

Published Print: 2023-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cortés-Hernández, Josefina

Marras Fernández-Cid, Carlos

Andreu Sánchez, Jose Luis

Calvo Alén, Jaime

García-Aparicio, Angel M.

Díez Álvarez, Elvira

Hidalgo Bermejo, Francisco Javier

Coronell, Carlos

Perna, Alessandra

Ordi Ros, Josep
License Information

Text and Data Mining valid from 2023-06-01

Text and Data Mining valid from 2023-06-01

Version of Record valid from 2022-08-26
More Information

This article is maintained by: Elsevier

Article Title: Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study

Journal Title: Reumatología Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reuma.2022.08.001

Content Type: article

Copyright: © 2022 The Authors. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below